Accumulation of protein-loaded long-circulating micelles and liposomes in subcutaneous Lewis lung carcinoma in mice

被引:142
作者
Weissig, V
Whiteman, KR
Torchilin, VP
机构
[1] Massachusetts Gen Hosp, Dept Radiol, Ctr Imaging & Pharmaceut Res, Charlestown, MA 02129 USA
[2] Harvard Univ, Sch Med, Charlestown, MA 02129 USA
关键词
tumor targeting; protein delivery; drug carriers; micelles; long-circulating liposomes; Lewis lung carcinoma;
D O I
10.1023/A:1011951016118
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. The purpose of our work was to compare the biodistribution and tumor accumulation of a liposome- or micelle-incorporated protein in mice bearing subcutaneously-established Lewis lung carcinoma. Methods. A model protein, soybean trypsin inhibitor (STI) was modified with a hydrophobic residue of N-glutaryl-phosphatidyl-ethanolamine (NGPE) and incorporated into both polyethyleneglycol (MW 5000)-distearoyl phosphatidyl ethanolamine (PEG-DSPE) micelles (< 20 nm) and PEG-DSPE-modified long-circulating liposomes (ca. 100 nm). The protein was labeled with In-111 via protein-attached diethylene triamine pentaacetic acid (DTPA), and samples of STI-containing liposomes or micelles were injected via the tail vein into mice bearing subcutaneously-established Lewis lung carcinoma. At appropriate time points, mice were sacrified and the radioactivity accumulated in the tumor and main organs was determined. Results. STI incorporated into PEG-lipid micelles accumulates in subcutaneously established Lewis lung carcinoma in mice better than the same protein anchored in long-circulating PEG-liposomes. Conclusions. Small-sized long-circulating delivery systems, such as PEG-lipid micelles, are more efficient in the delivery of protein to Lewis lune carcinoma than larger long-circulating liposomes.
引用
收藏
页码:1552 / 1556
页数:5
相关论文
共 17 条
[1]   Drug targeting in cancer therapy: The magic bullet, what next? [J].
Duncan, R ;
Connors, TA ;
Meada, H .
JOURNAL OF DRUG TARGETING, 1996, 3 (05) :317-319
[2]   DRUG POLYMER CONJUGATES - POTENTIAL FOR IMPROVED CHEMOTHERAPY [J].
DUNCAN, R .
ANTI-CANCER DRUGS, 1992, 3 (03) :175-210
[3]   LIPOSOME CIRCULATION TIME AND TUMOR TARGETING - IMPLICATIONS FOR CANCER-CHEMOTHERAPY [J].
GABIZON, AA .
ADVANCED DRUG DELIVERY REVIEWS, 1995, 16 (2-3) :285-294
[4]   Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment [J].
Hobbs, SK ;
Monsky, WL ;
Yuan, F ;
Roberts, WG ;
Griffith, L ;
Torchilin, VP ;
Jain, RK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (08) :4607-4612
[5]   HIGHLY EFFICIENT IMMUNOLIPOSOMES PREPARED WITH A METHOD WHICH IS COMPATIBLE WITH VARIOUS LIPID COMPOSITIONS [J].
HOLMBERG, E ;
MARUYAMA, K ;
LITZINGER, DC ;
WRIGHT, S ;
DAVIS, M ;
KABALKA, GW ;
KENNEL, SJ ;
HUANG, L .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 165 (03) :1272-1278
[6]   VASCULAR AND INTERSTITIAL BARRIERS TO DELIVERY OF THERAPEUTIC AGENTS IN TUMORS [J].
JAIN, RK .
CANCER AND METASTASIS REVIEWS, 1990, 9 (03) :253-266
[7]   ENHANCED TUMOR ACCUMULATION AND PROLONGED CIRCULATION TIMES OF MICELLE-FORMING POLY(ETHYLENE OXIDE-ASPARTATE) BLOCK COPOLYMER-ADRIAMYCIN CONJUGATES [J].
KWON, G ;
SUWA, S ;
YOKOYAMA, M ;
OKANO, T ;
SAKURAI, Y ;
KATAOKA, K .
JOURNAL OF CONTROLLED RELEASE, 1994, 29 (1-2) :17-23
[8]   BLOCK-COPOLYMER MICELLES AS LONG-CIRCULATING DRUG VEHICLES [J].
KWON, GS ;
KATAOKA, K .
ADVANCED DRUG DELIVERY REVIEWS, 1995, 16 (2-3) :295-309
[9]  
LASIC DD, 1993, LIPOSOMES PHYSICS AP, P54
[10]  
MATSUMURA Y, 1986, CANCER RES, V46, P6387